Amwill Health Care Ltd

Amwill Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Amwill Health Care Ltd

₹ 35.7 3.03%
09 Feb 4:01 p.m.
amwillhealthcare.com BSE - SME: 544353
About

Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]

Key Points

Business Overview:[1][2]
a) AHL focuses on Dermatology, Trichology, and Cosmetology.
b) It creates advanced skincare solutions using dermatological actives, natural ingredients, and specialized techniques.
c) Operates as a dermal-cosmetic developer, collaborating with contract manufacturers, distributors, and third-party developers.
d) Follows an asset-light model, outsourcing testing, manufacturing, and distribution.

Website BSE
  • Market Cap ₹ 71.4 Cr.
  • Current Price ₹ 35.7
  • High / Low ₹ 105 / 34.0
  • Stock P/E 8.84
  • Book Value ₹ 36.5
  • Dividend Yield 0.00 %
  • ROCE 27.6 %
  • ROE 24.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.98 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 46.1%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has high debtors of 163 days.
  • Working capital days have increased from 79.6 days to 166 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2024 Mar 2025 Sep 2025
23.16 17.43 21.21
14.32 14.62 17.10
Operating Profit 8.84 2.81 4.11
OPM % 38.17% 16.12% 19.38%
0.09 0.62 1.40
Interest 0.00 0.00 0.00
Depreciation 0.18 0.27 0.24
Profit before tax 8.75 3.16 5.27
Tax % 25.60% -33.54% 26.38%
6.52 4.21 3.87
EPS in Rs 4.18 2.10 1.93
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
17.23 26.20 28.45 41.59 37.35 38.64
18.25 22.45 24.16 24.93 25.70 31.72
Operating Profit -1.02 3.75 4.29 16.66 11.65 6.92
OPM % -5.92% 14.31% 15.08% 40.06% 31.19% 17.91%
0.00 -0.09 0.12 0.34 0.71 2.02
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.33 0.24 0.24 0.46 0.51
Profit before tax -1.03 3.33 4.17 16.76 11.90 8.43
Tax % -2.91% 22.82% 25.42% 25.48% 9.92%
-1.00 2.57 3.11 12.50 10.73 8.08
EPS in Rs -333.33 856.67 1,036.67 2,500.00 5.36 4.03
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 13%
TTM: -10%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 60%
TTM: -14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 46%
Last Year: 25%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.03 0.03 0.03 0.05 20.00 20.00
Reserves -1.12 1.46 4.57 17.11 49.21 53.09
0.12 0.12 0.04 0.00 0.00 0.00
9.26 4.97 7.76 1.82 2.27 4.94
Total Liabilities 8.29 6.58 12.40 18.98 71.48 78.03
0.80 0.44 0.52 0.61 1.20 1.50
CWIP 0.00 0.00 0.00 0.53 0.20 0.00
Investments 0.00 0.00 0.00 0.00 0.00 9.95
7.49 6.14 11.88 17.84 70.08 66.58
Total Assets 8.29 6.58 12.40 18.98 71.48 78.03

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.07 3.02 4.79 -3.06 5.56
-0.80 -0.06 -1.27 -1.39 -46.22
0.08 0.00 -0.09 -0.02 41.33
Net Cash Flow -0.66 2.96 3.43 -4.46 0.67

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 93.42 12.26 15.78 113.74 163.39
Inventory Days 66.49
Days Payable 39.35
Cash Conversion Cycle 93.42 12.26 15.78 140.88 163.39
Working Capital Days -44.70 -24.52 -38.23 111.02 166.13
ROCE % 1,068.75% 133.44% 153.49% 27.56%

Shareholding Pattern

Numbers in percentages

Mar 2025Sep 2025
70.65% 70.65%
1.16% 1.16%
28.19% 28.20%
No. of Shareholders 1,3741,606

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports